- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the effects of orteronel, when administered with prednisone, on the QT/QTc interval in patients with metastatic castration-resistant prostate cancer (mCRPC)
Inclusion criteria
- Metastatic Castration-resistant Prostate Cancer (mCRPC)